PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Ann Rheum Dis. 1978 April; 37(2): 175–179.
PMCID: PMC1001185

No effect of transfer factor in juvenile rheumatoid arthritis by double-blind trial.

Abstract

A previously pilot study of treatment with transfer factor in 3 patients with juvenile rheumatoid arthritis (JRA) gave promising results. However, in this small and open study no definite conclusions could be drawn. Therefore, a double-blind group trial was performed in 12 JRA patients treated with transfer factor, and in 12 placebo-treated control patients. The patients were evaluated clinically, by laboratory tests, and by estimation of different lymphocyte populations and cell-mediated immunity in vitro and in vivo. Transfer factor was not found to be of significant therapeutic value in patients with JRA. The only statistically significant difference between the two groups was a greater reduction in the percentage of T lymphocytes in transfer factor-treated patients than in control patients. The significance of this is difficult to explain and could have appeared by chance. No side effects of treatment with transfer factor were noted.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (708K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Amor, Brouihlet, Delbarre, Giroud, Kahan, Di Rosa, Velo, Turk, Willoughby, Timist, et al. New approaches to the evaluation of anti-rheumatic drugs. Agents Actions. 1974 Aug;4(3):169–172. [PubMed]
  • Calabro JJ, Marchesano JM. The early natural history of juvenile rheumatoid arthritis. A 10-year follow-up study of 100 cases. Med Clin North Am. 1968 May;52(3):567–591. [PubMed]
  • Froland SS, Natvig JB. Identification of three different human lymphocyte populations by surface markers. Transplant Rev. 1973;16:114–162. [PubMed]
  • Froland SS, Natvig JB, Hoyeraal HM, Kåss E. The principle of immunopotentiation in treatment of rheumatoid arthritis: effect of transfer factor. Scand J Immunol. 1974;3(2):223–228. [PubMed]
  • Gröhn P, Anttila R, Krohn K. The effect of non-specifically acting transfer factor component on cellular immunity in juvenile rheumatoid arthritis. Scand J Rheumatol. 1976;5(3):151–157. [PubMed]
  • Hoyeraal HM, Froland SS, Wisloff F. Lymphocyte populations and cellular immune reactions in juvenile rheumatoid arthritis. Scand J Immunol. 1975;4(8):801–810. [PubMed]
  • Husby G, Blomhoff JP, Skrede S, Elgjo K, Gjone E. Detection of immunoglobulins in paraffin-embedded liver biopsies. Studies in 100 patients with special regard to immunological findings in active chronic hepatitis. Scand J Gastroenterol. 1973;8(7):621–629. [PubMed]
  • Kåss E, Froland SS, Natvig JB, Blichfeldt P, Hoyeraal HM, Munthe E. A new principle of immunotherapy in rheumatoid arthritis: treatment with transfer factor. Scand J Rheumatol. 1974;3(3):113–117. [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group